Efficacy and Safety of ELOM-080 as Add-On Therapy in COVID-19 Patients with Acute Respiratory Insufficiency: Exploratory Data from the Prospective Placebo-Controlled COVARI Trial

INTRODUCTION: Enhancement of mucociliary clearance (MCC) might be a potential target in treating COVID-19. The phytomedicine ELOM-080 is an MCC enhancer that is used to treat inflammatory respiratory diseases. PATIENTS/METHODS: This randomised, double-blind exploratory study (EudraCT number 2020-003...

Descripción completa

Detalles Bibliográficos
Autores principales: Dreher, Michael, Grohè, Christian, Hartmann, Niels-Ulrik, Kanzler, Stephan, Kraft, Karin, Sarrazin, Christoph, Doll, Michael, Spiesshöfer, Jens, Steiner, Stephan, Wöhrle, Jochen, Seeger, Julia, Röschmann-Doose, Kristina, Thomsen, Jörn, Wittig, Thomas, Marx, Nikolaus, Eisenmann, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007397/
https://www.ncbi.nlm.nih.gov/pubmed/35419650
http://dx.doi.org/10.1007/s12325-022-02135-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007397/
https://www.ncbi.nlm.nih.gov/pubmed/35419650
http://dx.doi.org/10.1007/s12325-022-02135-z

Ejemplares similares